Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Krum

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
Australian and New Zealand Journal of Medicine|June 27, 2000
Sympathetic activation and the role of beta-blockers in chronic heart failureH Krum
The Medical Journal of Australia|July 21, 1997
Reducing the burden of chronic heart failureH Krum
The Medical Journal of Australia|July 7, 1997
Inhibitors of the renin-angiotensin systemH Krum
European Journal of Heart Failure|August 21, 2001
Pharmacoeconomics of beta-blockers: effective and cost-effective therapy in chronic heart failureH Krum, S Lim
Clinical and Experimental Pharmacology & Physiology|April 1, 1994
Spontaneous endothelin production by circulating mononuclear cells from patients with chronic heart failure but not from normal subjectsH Krum, S Itescu
Current Opinion in Investigational Drugs (London, England : 2000)|September 22, 2001
Eplerenone (GD Searle & Co)J Martin, H Krum
The Medical Journal of Australia|April 16, 1998
New drugs, old drugs. Beta-adrenoceptor blocking agentsH Krum, P Pillay
Internal Medicine Journal|December 6, 2003
New and emerging drug therapies for the management of acute heart failureH Krum, D Liew
Clinical Chemistry|September 1, 1988
Intra-individual variability of plasma cholesterol concentrationsL G Howes, H Krum
The Medical Journal of Australia|November 27, 1998
The short life and rapid death of a novel antihypertensive and antianginal agentH Krum, J J McNeil
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
Australian and New Zealand Journal of Medicine|June 27, 2000
Sympathetic activation and the role of beta-blockers in chronic heart failureH Krum
The Medical Journal of Australia|July 21, 1997
Reducing the burden of chronic heart failureH Krum
The Medical Journal of Australia|July 7, 1997
Inhibitors of the renin-angiotensin systemH Krum
European Journal of Heart Failure|August 21, 2001
Pharmacoeconomics of beta-blockers: effective and cost-effective therapy in chronic heart failureH Krum, S Lim
Clinical and Experimental Pharmacology & Physiology|April 1, 1994
Spontaneous endothelin production by circulating mononuclear cells from patients with chronic heart failure but not from normal subjectsH Krum, S Itescu
Current Opinion in Investigational Drugs (London, England : 2000)|September 22, 2001
Eplerenone (GD Searle & Co)J Martin, H Krum
The Medical Journal of Australia|April 16, 1998
New drugs, old drugs. Beta-adrenoceptor blocking agentsH Krum, P Pillay
Internal Medicine Journal|December 6, 2003
New and emerging drug therapies for the management of acute heart failureH Krum, D Liew
Clinical Chemistry|September 1, 1988
Intra-individual variability of plasma cholesterol concentrationsL G Howes, H Krum
The Medical Journal of Australia|November 27, 1998
The short life and rapid death of a novel antihypertensive and antianginal agentH Krum, J J McNeil
Pageof 12